Form 4 for OMDA Omada Health, Inc.
Accepted 2026-06-16 16:54:53 ET · period of report 2026-06-12 · accession 0001610717-26-000224 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-06-16 16:54 | 2026-06-12 | OMDA | Shao Wei-Li | Pres | S - Sale | $17.24 | -4,589 | 316.2K | -1% | -$79.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-12 | S | D | 4,589 | $17.24 | 316,238 | D | — | — | (F1) Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026. (F2) This transaction was executed in multiple trades at prices ranging from $17.10 to $17.54. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |